Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01)-Reference-Cited by-同舟云学术

Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01)

Published:2019-11 Issue:3 Volume:105 Page:606-617
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hayashi Tsuyoshi,Nakamura Toru,Kimura Yasutoshi,Yoshida Makoto,Someya Masanori^ORCID,Kawakami Hiroshi,Sakuhara Yusuke^ORCID,Katoh Norio,Takahashi Kuniyuki,Ambo Yoshiyasu,Miura Katsutoshi,Motoya Masayo,Tanaka Eiichi,Murakawa Katsuhiko,Yamabuki Takumi,Yamazaki Hajime,Katanuma Akio,Hirano Satoshi

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: Expert consensus statement;Callery;Ann Surg Oncol,2009

3. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: A prospective, randomized, open-label, multicenter phase 2/3 trial;Jang;Ann Surg,2018

4. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): Study protocol for a multicentre randomized controlled trial;Versteijne;Trials,2016

5. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: Preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas;Katz;BMC Cancer,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant therapy with intensity‐modulated radiotherapy combined with S‐1 for borderline‐resectable pancreatic cancer;Asia-Pacific Journal of Clinical Oncology;2024-05-21

2. Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer;Journal of Gastrointestinal Cancer;2024-02-13

3. Reconsidering resectable oncological conditions in pancreatic tail cancer: A multicenter retrospective study on prognostic factors in pancreatic tail cancer after resection (HOPS Pt-01);Pancreatology;2024-02

4. Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer – A review;Heliyon;2024-01

5. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma;American Journal of Clinical Oncology;2023-12-22